Facilitating strategic connections
that drive life science dealmaking.
6 Global events
11,644 Executive-level attendees attracted
48,347 One-to-one partnering meetings held
6,673 Attending companies
60 Countries represented
12,193 Licensing opportunities on offer
We consistently provide valuable in-depth insight and analysis on the most recent trends in life science and partnering. Don't miss the latest releases!
Get the facts before you make your next deal. This newly published report reveals an analysis and review of the last 18 months of biopharma dealmaking. Alongside venture capital and public market investment, biopharmaceutical company alliances remain key sources of capital for advancing drug discovery and development efforts across the industry. Download this FREE report now.
Gain insight for your next alliance with this report. For the third year, Pharma Intelligence and EBD Group are identifying key trends around core elements of the partnering journey, by assessing the potential for currently unpartnered assets, revisiting the relationships built through in-person meetings at BIO-Europe, and analyzing the dealmaking activity from the last year.
In the past year, digital medicine has continued to define and refine the ways we think about health and providing care for individuals and populations. See what’s on the horizon for 2019. Download the Digital Medicine 2018 Report: Part 1- Innovation Supported by Regulation and read how the FDA is forging into new territory and folding digital medicine into the regulatory process.
partneringONE is even more powerful than before. New features and functionality will increase your productivity and improve your partnering experience. Look out for a mobile-responsive platform, time-saving message templates and enhanced search capabilities and collaboration tools.FIND OUT MORE